Mark Wong - PT Lippo Investor Relations Director
| PTLKF Stock | USD 0 0.00 0.00% |
Director
Mr. Mark Wong serves as Senior Executive Officer and IR Contact Officer of PT Lippo Karawaci Tbk since 2016. He holds a degree in Business from University of Pennsylvania and University of Singapore. He was Country Representative of five banks in Singapore and was involved in a study of ADB. He is founder of Asosiasi Modal Ventura Indonesia and Asia Pacific VC Alliance . since 2016.
| Age | 68 |
| Tenure | 8 years |
| Phone | 62 21 2566 9000 |
| Web | https://www.lippokarawaci.co.id |
PT Lippo Management Efficiency
PT Lippo's management efficiency ratios could be used to measure how well PT Lippo manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Kathryn Lisson | QBE Insurance Group | 66 | |
| Raymond Neff | Maiden Holdings | 78 | |
| Simcha Lyons | Maiden Holdings | 73 | |
| Charles Koch | Assurant | 72 | |
| JeanPaul Montupet | Assurant | 73 | |
| Lawrence Jackson | Assurant | 67 | |
| Edward Yun | Kinsale Capital Group | 49 | |
| John Green | QBE Insurance Group | 63 | |
| Rolf Tolle | QBE Insurance Group | 68 | |
| Patrick Regan | QBE Insurance Group | 52 | |
| Elyse Douglas | Assurant | 61 | |
| James Ritchie | Kinsale Capital Group | 65 | |
| Brian Pomeroy | QBE Insurance Group | 72 | |
| Ognjen Redzic | Assurant | 50 | |
| Paget Alves | Assurant | 66 | |
| Frederick Russell | Kinsale Capital Group | 60 | |
| Yehuda Neuberger | Maiden Holdings | 43 | |
| Debra Perry | Assurant | 69 | |
| Stephen Fitzgerald | QBE Insurance Group | 53 | |
| Howard Carver | Assurant | 72 | |
| Juan Cento | Assurant | 69 | |
Management Performance
| Return On Equity | -0.13 | |||
| Return On Asset | 0.0078 |
PT Lippo Karawaci Leadership Team
Elected by the shareholders, the PT Lippo's board of directors comprises two types of representatives: PT Lippo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PTLKF. The board's role is to monitor PT Lippo's management team and ensure that shareholders' interests are well served. PT Lippo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PT Lippo's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bartholomeus Toto, Senior Executive Officer - Lippo Homes | ||
| Tanri Abeng, Independent Commissioner | ||
| Heok Lee, Director | ||
| Marshal Tissadharma, Director | ||
| Julie McCaughan, Senior Executive Officer - Siloam Hospitals | ||
| Ninik Nathan, Director | ||
| Johanes Jany, Director | ||
| Soerjadi Soedirdja, Vice President Commissioner, Independent Commissioner | ||
| Farid Harianto, Independent Commissioner | ||
| Jenny Kuistono, Corporate Secretary and Director | ||
| Muladi, Independent Commissioner | ||
| Ketut Wijaya, Pres Director | ||
| Anthony Ross, Senior Executive Officer - Hotels & Hospitality | ||
| Viven Sitiabudi, Commissioner | ||
| Alwi Sjaaf, Independent Director | ||
| Gordon Benton, Senior Executive Officer | ||
| Budi Legowo, Senior Executive Officer - Siloam Hospitals | ||
| Sri Handoyo, Corporate Secretary | ||
| William Utama, IR Contact Officer | ||
| Chong Meow, Senior Executive Officer | ||
| H Sutiyoso, Commissioner | ||
| Eddy Mumin, Senior Executive Officer - Lippo Malls | ||
| Caroline Riady, Senior Executive Officer - Siloam Hospitals | ||
| Theo Sambuaga, President Commissioner, Independent Commissioner | ||
| Marshall Tissadharma, Senior Executive Officer - Lippo Malls | ||
| Romeo Lledo, Senior Executive Officer - Siloam Hospitals | ||
| Norita Alex, Director - Talent Administration | ||
| Surjadi Soedirdja, Vice President Commissioner, Independent Commissioner | ||
| Kooi Choo, Director | ||
| Grace Indradjaja, Senior Executive Officer - Siloam Hospitals | ||
| Dion Leswara, Chief Director | ||
| Chee Chan, Director | ||
| Edward Ng, Senior Executive Officer - Lippo Malls | ||
| Rudy Halim, COO Director | ||
| Krishnadi Kartawidjaja, Chief Devel | ||
| Tjokro Libianto, Director | ||
| Rahmawaty, Director | ||
| Andi Anzhar, Senior Executive Officer - Lippo Homes | ||
| Bret Ginesky, Head Relations | ||
| Donny Susanto, Chief Controller | ||
| John Riady, CEO Director | ||
| Surya CFA, Chief Director | ||
| Benny Djie, Commissioner | ||
| Budiraharjo Legowo, Senior Executive Officer - Siloam Hospitals | ||
| Agum Gumelar, Independent Commissioner | ||
| Juergen Fischer, Senior Executive Officer - Hotels & Hospitality | ||
| Kah Hong, Controller | ||
| Anwar Salim, Senior Executive Officer - Lippo Malls | ||
| Danang Jati, Head Communications | ||
| Sunil Ithikatt, Senior Executive Officer - Hotel | ||
| Anang Prayudi, Senior Executive Officer - Siloam Hospitals | ||
| Sugianganto Budisuharto, Senior Executive Officer - Siloam Hospitals | ||
| Gershu Chandy, Senior Executive Officer | ||
| Siek Yohandra, Senior Executive Officer - Lippo Homes | ||
| Jopy Rusli, Chief Officer | ||
| Hendra Sidin, Vice President Director | ||
| Richard Setiadi, Director | ||
| Wijaya Subekti, Director | ||
| Mark Wong, Investor Relations Director | ||
| Meng Phua, CFO Director | ||
| Andry, Senior Executive Officer - Siloam Hospitals | ||
| Ivan Budiono, Director | ||
| Susan Tedjadinata, Senior Executive Officer - Lippo Homes | ||
| Marshall Martinus, Senior Executive Officer - Lippo Malls | ||
| Purnomo Utoyo, Senior Executive Officer - Lippo Homes |
PTLKF Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is PT Lippo a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.13 | |||
| Return On Asset | 0.0078 | |||
| Profit Margin | (0.20) % | |||
| Current Valuation | 1.54 B | |||
| Shares Outstanding | 70.8 B | |||
| Shares Owned By Insiders | 55.70 % | |||
| Shares Owned By Institutions | 4.00 % | |||
| Price To Earning | 19.00 X | |||
| Price To Book | 0.54 X | |||
| Price To Sales | 0.62 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards PT Lippo in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, PT Lippo's short interest history, or implied volatility extrapolated from PT Lippo options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as PT Lippo Karawaci using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PT Lippo Karawaci. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for PTLKF Pink Sheet analysis
When running PT Lippo's price analysis, check to measure PT Lippo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PT Lippo is operating at the current time. Most of PT Lippo's value examination focuses on studying past and present price action to predict the probability of PT Lippo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PT Lippo's price. Additionally, you may evaluate how the addition of PT Lippo to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |